Capra Biosciences

About

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals.

Alexandria,Virginia,United States
1 - 10

Highlights

Details

Last Funding Type: Pre-seed
Last Funding Money Raised: $1.80M
Industries: Biotechnology,Chemical,Life Science
Founded date: Jan 1, 2020
Number Of Employee: 1 - 10
Operating Status: Active

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.

Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$1.80M

Capra Biosciences has raised a total of $1.80M in funding over 2 rounds. Their latest funding was raised on Jun 6, 2022 from a Pre-seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 6, 2022	Pre-seed	$1.80M	9	—	—	Detail
Jan 18, 2022	Convertable Note	—	2	—	—	Detail
Jan 14, 2022	Pre-seed	—	1	—	—	Detail
Jun 3, 2021	Convertable Note	—	1	—	—	Detail
Nov 13, 2020	Pre-seed	—	2	SOSV	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

10

Capra Biosciences is funded by 10 investors. Savantus Ventures and Decarbonization Consortium are the most recent investors.

Investor Name	Lead Investor	Funding Round
Savantus Ventures	—	Pre-seed
Decarbonization Consortium	—	Pre-seed
Asymmetry Ventures	—	Pre-seed
GS Futures	—	Pre-seed
Prithvi Ventures	—	Pre-seed
SOSV	—	Pre-seed
The E14 Fund	—	Pre-seed
Vishal Rao	—	Pre-seed
Wes Osbourn	—	Pre-seed
IndieBio	—	Convertable Note